ArticlePharmacological reports : PR2021

The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome.

Robert Krysiak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.